Generic drugmakers seek US antitrust trial delays; Teva says it fears anti-Israel bias
Major US generic pharmaceutical manufacturers involved in sprawling price-fixing litigation are seeking delays to a bellwether price-fixing case brought by Humana that's scheduled for a September trial.Major US generic pharmaceutical manufacturers...To view the full article, register now.
Already a subscriber? Click here to view full article